Andra AP-fonden’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.8M | Buy |
55,007
+48,327
| +723% | +$12M | 0.16% | 154 |
|
|
2025
Q4 | $1.84M | Buy |
+6,680
| New | +$1.83M | 0.02% | 366 |
|
|
2024
Q4 | – | Sell |
-26,000
| Closed | -$7.8M | – | 465 |
|
|
2024
Q3 | $7.8M | Buy |
26,000
+1,000
| +4% | +$306K | 0.11% | 258 |
|
|
2024
Q2 | $8.23M | Buy |
25,000
+4,700
| +23% | +$1.66M | 0.14% | 233 |
|
|
2024
Q1 | $8.03M | Buy |
+20,300
| New | +$7.51M | 0.14% | 220 |
|
|
2023
Q3 | – | Sell |
-25,200
| Closed | -$9.64M | – | 574 |
|
|
2023
Q2 | $9.64M | Sell |
25,200
-500
| -2% | -$179K | 0.24% | 120 |
|
|
2023
Q1 | $8.9M | Sell |
25,700
-18,200
| -41% | -$5.32M | 0.23% | 155 |
|
|
2022
Q4 | $10.3M | Buy |
43,900
+3,500
| +9% | +$829K | 0.31% | 49 |
|
|
2022
Q3 | $9.94M | Buy |
40,400
+5,900
| +17% | +$1.8M | 0.33% | 53 |
|
|
2022
Q2 | $10.4M | Buy |
+34,500
| New | +$11.2M | 0.3% | 69 |
|
|
2021
Q4 | $16M | Sell |
34,200
-300
| -0.9% | -$129K | 0.33% | 48 |
|
|
2021
Q3 | $14.6M | Buy |
34,500
+3,000
| +10% | +$1.26M | 0.3% | 53 |
|
|
2021
Q2 | $11.3M | Sell |
31,500
-1,000
| -3% | -$330K | 0.23% | 130 |
|
|
2021
Q1 | $9.16M | Sell |
32,500
-16,200
| -33% | -$4.64M | 0.2% | 209 |
|
|
2020
Q4 | $13.8M | Sell |
48,700
-3,500
| -7% | -$982K | 0.3% | 32 |
|
|
2020
Q3 | $14.3M | Buy |
52,200
+7,800
| +18% | +$2.06M | 0.39% | 6 |
|
|
2020
Q2 | $10.1M | Buy |
44,400
+11,600
| +35% | +$2.28M | 0.29% | 15 |
|
|
2020
Q1 | $4.99M | Sell |
32,800
-5,800
| -15% | -$893K | 0.18% | 185 |
|
|
2019
Q4 | $5.8M | Buy |
+38,600
| New | +$5.62M | 0.17% | 286 |
|
Other funds holding WST
VCM
VPM
GIM
